Biomarker-based diagnosis of preclinical Alzheimer disease: time for the clinic?

Authors

Marwan N. Sabbagh, Alzheimer's Clinical and Translational Research Lab, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA. neuropub@barrowneuro.org.
Boris DeCourt, Translational Neurodegenerative Research Lab, Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA.

Document Type

Article

Medical Subject Headings

Humans; Alzheimer Disease (diagnosis); Amyloid beta-Peptides; Biomarkers

Publication Date

2-1-2023

Publication Title

Nature reviews. Neurology

E-ISSN

1759-4766

Volume

19

Issue

2

First Page

71

Last Page

72

PubMed ID

36627511

Digital Object Identifier (DOI)

10.1038/s41582-022-00767-x

Recommended Citation

Sabbagh, Marwan N. and DeCourt, Boris, "Biomarker-based diagnosis of preclinical Alzheimer disease: time for the clinic?" (2023). Neurology. 1466.
https://scholar.barrowneuro.org/neurology/1466